Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 16 AL 30

Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease

Monsalvo-Maraver LÁ, Maya-López M, Rangel-López E, Túnez I, Tinkov AA, Skalny A, Ferrer B, Aschner M, Santamaría A.

CNS Neurol Disord Drug Targets. 2023;22(7):1039-1056. doi: 10.2174/1871527321666220616094036.

DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease

de Souza MM, Cenci AR, Teixeira KF, Machado V, Mendes Schuler MCG, Gonçalves AE, Paula Dalmagro A, André Cazarin C, Gomes Ferreira LL, de Oliveira AS, Andricopulo AD.

Curr Med Chem. 2023;30(6):669-688. doi: 10.2174/0929867329666220620162018.

Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease

Das S, Ramachandran AK, Halder D, Akbar S, Ahmed B, Joseph A.

CNS Neurol Disord Drug Targets. 2023;22(7):973-993. doi: 10.2174/1871527321666220629162229.

Anticholinesterase Agents For Alzheimer's Disease Treatment: An Updated Overview

Llanes LC, Kuehlewein I, França IV, da Silva LV, da Cruz Junior JW.

Curr Med Chem. 2023;30(6):701-724. doi: 10.2174/0929867329666220803113411.

Genetic Causes of Alzheimer's Disease and the Neuroprotective Role of Melatonin in its Management

Sundram S, Malviya R, Awasthi R.

CNS Neurol Disord Drug Targets. 2023;22(9):1302-1312. doi: 10.2174/1871527321666220901125730.

Current Naturopathy to Combat Alzheimer's Disease

Chakrovorty A, Bhattacharjee B, Saxena A, Samadder A, Nandi S.

Curr Neuropharmacol. 2023;21(4):808-841. doi: 10.2174/1570159X20666220927121022.

Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment

Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, Patel S, Patel A, Patel V, Patel B.

CNS Neurol Disord Drug Targets. 2023;22(10):1462-1471. doi: 10.2174/1871527322666221005124808.

Recent Advances in the Development of Nitrogen-containing Heterocyclic Anti-alzheimer's Agents

Kumar A, Nehra B, Singh D, Kumar D, Chawla PA.

Curr Top Med Chem. 2023;23(13):1277-1306. doi: 10.2174/1568026623666221019152502.

A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease

Chen L, Xue J, Zhao Q, Liang X, Zheng L, Fan Z, Souare ISJ, Suo Y, Wei X, Ding D, Mao Y.

J Alzheimers Dis. 2023;91(1):191-201. doi: 10.3233/JAD-220866.

Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives

Zakharova L, Gaynanova G, Vasilieva E, Vasileva L, Pavlov R, Kashapov R, Petrov K, Sinyashin O.

Curr Med Chem. 2023;30(33):3743-3774. doi: 10.2174/0929867330666221115103513.

Natural Products with BACE1 and GSK3β Inhibitory Activity

Prado PC, Lima JA, Hamerski L, Rennó MN.

Mini Rev Med Chem. 2023;23(7):881-895. doi: 10.2174/1389557523666221118113923.

Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities

Zhang R, Song Y, Su X.

J Alzheimers Dis. 2023;94(s1):S367-S386. doi: 10.3233/JAD-220809.

Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease

Yamali C, Donmez S.

Mini Rev Med Chem. 2023;23(7):869-880. doi: 10.2174/1389557523666221201145141.

NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease

Painuli S, Semwal P, Zam W, Taheri Y, Ezzat SM, Zuo P, Li L, Kumar D, Sharifi-Rad J, Cruz-Martins N.

Comb Chem High Throughput Screen. 2023;26(12):2099-2112. doi: 10.2174/1386207325666220428112541.

Role of Polyphenols in Alleviating Alzheimer's Disease: A Review

William Raja TR, Duraipandiyan V, Ignacimuthu S, Janakiraman U, Packiam SM.

Curr Med Chem. 2023;30(35):4032-4047. doi: 10.2174/0929867330666221202152540.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias